Correlation between Circulating Fungal Biomarkers and Clinical Outcome in Invasive Aspergillosis.
Objective means are needed to predict and assess clinical response in patients treated for invasive aspergillosis (IA). We examined whether early changes in serum galactomannan (GM) and/or β-D-glucan (BDG) can predict clinical outcomes. Patients with proven or probable IA were prospectively enrolled...
Main Authors: | Dionysios Neofytos, Radha Railkar, Kathleen M Mullane, David N Fredricks, Bruno Granwehr, Kieren A Marr, Nikolaos G Almyroudis, Dimitrios P Kontoyiannis, Johan Maertens, Rebecca Fox, Cameron Douglas, Robert Iannone, Eunkyung Kauh, Norah Shire |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4480423?pdf=render |
Similar Items
-
Detection of urinary excreted fungal galactomannan-like antigens for diagnosis of invasive aspergillosis.
by: Simon F Dufresne, et al.
Published: (2012-01-01) -
Standards in prophylaxis: Prevention of invasive aspergillosis in patients with hematologic malignancies
by: D. Kontoyiannis
Published: (2014-04-01) -
Aspergillosis Complicating Severe Coronavirus Disease
by: Kieren A. Marr, et al.
Published: (2021-01-01) -
Invasive aspergillosis in solid organ transplant patients: diagnosis, prophylaxis, treatment, and assessment of response
by: Dionysios Neofytos, et al.
Published: (2021-03-01) -
768 Re-directed T cell therapy to control invasive aspergillosis
by: Pappanaicken Kumaresan, et al.
Published: (2020-11-01)